Tinidazole: Clinical Trials

29 trials of Tinidazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 10 unknown, 2 not yet recruiting, 2 withdrawn. 13 Phase 4, 5 Not applicable, 5 Phase 3, 4 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 413Completed 5, Unknown 5, Not yet recruiting 1, Terminated 1, Withdrawn 1
Not applicable5Unknown 3, Completed 1, Not yet recruiting 1
Phase 35Completed 3, Unknown 2
Phase 24Completed 2, Recruiting 1, Withdrawn 1
Early Phase 11Completed 1
Phase 11Completed 1

Follow Tinidazole: new trials by email Literature Review of Tinidazole trials Research Report on Tinidazole

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vonoprazan High-Dose Dual VS Levofloxacin Concomitant
Vonoprazan, Levofloxacin 500mg - Helicobacter Pylori Infection, Peptic Ulcer Disease
Phase 4Not yet recruitingDamascus Hospital1502026-11-012026-06-03
Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
Metronidazole, Tinidazole 500mg, tetracyline - Helicobacter Pylori Infection
Not applicableNot yet recruitingUniversity of Medicine and Pharmacy at Ho Chi Minh City6002026-07-272026-08-05
"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"
Tinidazole - Mycoplasma Genitalium, Non-gonococcal Urethritis (NGU)
Phase 2RecruitingUniversity of Washington402025-07-232026-05-04
Effectiveness of Rifabutin for Treatment of Helicobacter Pylori
Rifabutin, Amoxicillin, Esomeprazole - Helicobacter Infections, Resistance Bacterial
Phase 3UnknownRabin Medical Center3002021-05-012021-03-10
Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy
Sulperazon, Teicoplanin, Meropenem Injection - Cholangitis, Secondary Biliary, Treatment Compliance
Phase 4CompletedTongji Hospital1602021-05-012022-04-11
Eradication of H. Pylori Infection With Moxifloxacin
Sequential Regimen: Levofloxacin 500 mg BID, Amoxicillin 1 gm BID, omeprazole 20 mg BID for first five days followed by Levofloxacin 500 mgBID, Tinidazole 500 mg BID, Omeprazole 20 mg BID, Triple Regimen: Moxifloxacin 400mg OD, Amoxicillin 1 gm BID, Omeprazole 20mgBID - Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to
Phase 3CompletedIyad Naeem Muhammad, PhD1622020-06-012023-05-18
Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin
Levofloxacin, tinidazole - Helicobacter Pylori Infection
Phase 4UnknownShandong University2502019-11-012021-11-18
Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin
Furazolidone, Tinidazole - Helicobacter Pylori Infection
Phase 4UnknownShandong University2502019-11-012021-11-18
Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
two sensitive antibiotics(amoxicillin, clarithromycin, metronidazole, tinidazole, levofloxacin, furazolidone and tetracycline), one proton pump inhibitor, colloidal bismuth pectin, two antibiotics based on personal medication history(amoxicillin,levofloxacin, furazolidone) - Helicobacter Pylori Infection
Phase 4CompletedShandong University4202019-01-012020-05-12
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
two sensitive antibiotics(amoxicillin, clarithromycin, metronidazole, tinidazole, levofloxacin, furazolidone and tetracycline), two antibiotics based on personal medication history(amoxicillin,clarithromycin,furazolidone), one proton pump inhibitor(PPI) - Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing
Phase 4UnknownShandong University4002018-07-012018-06-27
The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar
Clarithromycin 500mg, Amoxicillin 500mg, Tinidazole 500mg - Helicobacter Pylori Infection
Phase 4CompletedKirby Institute3132018-01-012019-10-18
Effect of Antibiotics on Penile Microbiome and HIV Susceptibility Study in Ugandan Men
Oral Tinidazole, Topical metronidazole, Topical Clindamycin - Foreskin HIV Susceptibility
Not applicableUnknownUniversity of Toronto1252017-12-072018-01-26
Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori
Clarithromycin 500Mg Oral Tablet, Levofloxacin 500Mg Oral Tablet - Helicobacter Pylori Gastrointestinal Tract Infection
Phase 4WithdrawnDamascus Hospital2017-06-012018-12-07
Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
amoxicillin, clarithromycin, tinidazole - Antimicrobial Susceptibility Testing, Triple Therapy
Phase 4UnknownYanqing Li1202017-05-302017-05-03
Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment
Clarithromycin susceptibility dependant strategy, 2 susceptible antibiotics (amoxicillin, clarithromycin, metronidazole, tinidazole,levofloxacin, furazolidone and tetracycline ), proton pump inhibitor (PPI) and Colloidal Bismuth Pectin - Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing
Phase 4UnknownShandong University4802017-04-202017-04-25
Treatment of Giardia Lamblia Infections in Children
Metronidazole, Tinidazole - GIARDIASIS
Phase 4TerminatedHelsinki University Central Hospital82016-12-012020-11-18
Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
Nexium, Tinafas, Tavanex - Helicobacter Infection
Phase 4CompletedZahra Vahdat Shariatpanahi2122016-09-012017-06-08
RCT(Randomized Clinical Trial ) of Antibiotic Therapy in Chronic Endometritis
Antibiotics - Chronic Endometritis
Not applicableCompletedFu Xing Hospital, Capital Medical University1202016-01-102022-02-07
Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea
Tinidazole and Albendazole, Placebo control - Chronic Diarrhea, Abdominal Pain
Not applicableUnknownSheba Medical Center1002012-03-012014-08-27
5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection
Eradication therapy (amoxicillin; esomeprazole; tinidazole; levofloxacin) - Helicobacter Pylori Infection
Phase 3CompletedUniversity of Campania Luigi Vanvitelli1802011-01-012012-03-06

Showing 20 of 29. Sign in to see all of them.

Conditions studied

Vaginosis, Bacterial (5)  ·  Helicobacter Infections (3)  ·  Abdominal Pain (1)  ·  Biliary Atresia (1)  ·  Cholangitis (1)  ·  Gastritis (1)  ·  Giardiasis (1)  ·  Liver Cirrhosis, Biliary (1)  ·  Malaria (1)  ·  Malaria, Vivax (1)  ·  Patient Compliance (1)  ·  Peptic Ulcer (1)  ·  Recurrence (1)  ·  Sexually Transmitted Diseases (1)  ·  Stomach Neoplasms (1)

Sponsors

Shandong University (5)  ·  Damascus Hospital (2)  ·  Fu Xing Hospital, Capital Medical University (1)  ·  Helsinki University Central Hospital (1)  ·  Iyad Naeem Muhammad, PhD (1)  ·  Kaiser Permanente (1)  ·  Kirby Institute (1)  ·  Lymphoma Trials Office (1)  ·  Mission Pharmacal (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Rabin Medical Center (1)  ·  Roxane Laboratories (1)  ·  Sheba Medical Center (1)  ·  Tongji Hospital (1)  ·  University of Alabama at Birmingham (1)

Countries

China (7)  ·  United States (7)  ·  Syria (2)  ·  Brazil (1)  ·  Burma (1)  ·  Finland (1)  ·  Hong Kong (1)  ·  Iran (1)  ·  Israel (1)  ·  Italy (1)  ·  Pakistan (1)  ·  Poland (1)  ·  South Africa (1)  ·  Switzerland (1)  ·  Thailand (1)

Top investigators

Li Yanqing, MD, PhD (2)  ·  Xiuli Zuo, MD,PhD (2)  ·  Xiuli Zuo, PhD,MD (2)  ·  Barry W. Hancock, MD (1)  ·  Dongmei Song, Master (1)  ·  Doron Boltin, MBBS (1)  ·  Enlan Xia, Master (1)  ·  Feng Jiexiong, Postdoctoral (1)  ·  Francois Nosten, MD (1)  ·  Iyad N Muhammad, Ph.D. (1)  ·  Jane Schwebke, MD (1)  ·  Jennifer Gunter, MD (1)  ·  Jose A Simoes, MD, PhD (1)  ·  Lisa Manhart, PhD (1)  ·  Mar Mar Kyi, MD (1)

Results publications

PMID 11197288, PMID 11895791, PMID 16441468, PMID 17666604, PMID 19036078, PMID 21288838, PMID 23718705, PMID 26207958, PMID 30635887, PMID 31324206, PMID 32365359, PMID 33037845, PMID 33549312, PMID 37678274, PMID 39214083

NIH funding

R01AI058033 (1)